@nameuser778901: Жеп қалу 🤣 #чупапрайм #рекомендации #chupa #хит #fyp

Чупа милый
Чупа милый
Open In TikTok:
Region: KZ
Thursday 09 July 2026 14:35:25 GMT
48620
2511
58
3100

Music

Download

Comments

whyshawn02
whyshawn :
0.001% прайм
2026-07-09 19:14:39
304
sss_big
Байбек :
чупа красавчик
2026-07-09 20:28:01
128
qwerty_777.3
Рамазан :
До конца шыдады
2026-07-10 03:38:43
39
saynoanime
Max Holloway :
Прайм Чупа
2026-07-10 05:25:19
15
8woxow8
BIMBILIMBIM :
Достойные соперники
2026-07-10 12:13:39
3
alibek001rk
Алибек :
2026-07-09 18:13:11
11
expert_08
YA POZHYZNY POHUIST :
2026-07-11 22:55:31
0
muh_.017
muh_017 :
2026-07-10 17:27:21
2
4113l2
🕳️ :
2026-07-10 12:29:44
1
nake0170
user4412650396225 :
2026-07-11 01:14:22
0
andrei.makish
Хенрик Ларссон :
2026-07-10 08:36:02
0
To see more videos from user @nameuser778901, please go to the Tikwm homepage.

Other Videos

Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only.  ------  What is HEMLIBRA?  HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors.  ------  What is the most important information I should know about HEMLIBRA?  HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots.  --  These serious side effects include:  • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs  • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head  --  Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total.  --  Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds).  --  The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.

About